FDA Approves Lazanda (Fentanyl) Nasal Spray for Breakthrough Cancer Pain
Links shared publicly online about this topic.
- 180total visits
FDA Approves Lazanda (Fentanyl) Nasal Spray for Breakthrough Cancer Pain
View full resource at disabled-world.com
Tags: Pain, Cancer, Cancer Pain Medication, Nose, FDA, Duragesic, Actiq
Most Recently Shared on June 30, 2011 at 11:03 pm By:
FDA Approves Lazanda (Fentanyl) Nasal Spray for Breakthrough Cancer Pain http://ff.im/-H07aY
FDA Approves First Fentanyl Nasal Spray for Breakthrough Cancer Pain
onclive.com — “FDA approvad Lazanda (fentanyl) nasal spray for the management of breakthrough pain in adult cancer patients.” View full resource at onclive.com
Most Recently Shared on July 12, 2011 at 9:12 pm By:
FDA Approves First Fentanyl Nasal Spray for Breakthrough Cancer Pain http://t.co/Y6yfAk9
Medical News: FDA Okays Nasal Spray for Ca Pain - in Public Health & Policy, FDA General from MedPage Today
medpagetoday.com — “WASHINGTON -- The FDA has approved a nasal spray formulation of the drug fentanyl (Lazanda) to manage breakthrough pain in cancer patients 18 and older who are already using opioid therapy.” View full resource at medpagetoday.com
Most Recently Shared on July 5, 2011 at 4:51 pm By:
New nasal spray to treat pain in cancer patients is approved by the #FDA http://bit.ly/k9MyZr
FDA Okays Nasal Spray for Ca Pain - QualityPoint Technologies
qualitypointtech.net — “WASHINGTON (MedPage Today) -- The FDA has approved a nasal spray formulation of the drug fentanyl (Lazanda) to manage breakthrough pain in cancer patients 18 and older who are already using opioid therapy.” View full resource at qualitypointtech.net
Most Recently Shared on July 2, 2011 at 1:45 pm By:
FDA Okays Nasal Spray for Ca Pain: WASHINGTON (MedPage Today) -- The FDA has approved a nasal spray formulation of... http://bit.ly/mpdinQ
Medical News: FDA Okays Nasal Spray for Ca Pain - in Public Health & Policy, FDA General from MedPage Today
medpagetoday.com — “WASHINGTON -- The FDA has approved a nasal spray formulation of the drug fentanyl (Lazanda) to manage breakthrough pain in cancer patients 18 and older who are already using opioid therapy.” View full resource at medpagetoday.com
Most Recently Shared on July 2, 2011 at 1:27 pm By:
FDA Okays Nasal Spray for Ca Pain http://bit.ly/l97juH
Medical News: FDA Okays Nasal Spray for Ca Pain - in Public Health & Policy, FDA General from MedPage Today
medpagetoday.com — “WASHINGTON -- The FDA has approved a nasal spray formulation of the drug fentanyl (Lazanda) to manage breakthrough pain in cancer patients 18 and older who are already using opioid therapy.” View full resource at medpagetoday.com
Most Recently Shared on July 2, 2011 at 1:16 pm By:
FDA Okays Nasal Spray for Ca Pain http://bit.ly/j6KrSw
Lazanda Approved for Cancer Pain
health.yahoo.net — “FRIDAY, July 1 (HealthDay News) -- Lazanda (fentanyl) nasal spray has been approved by the U.S. Food and Drug Administration to treat breakthrough pain in adults with cancer who are already receiving opioid therapy, drug maker Archimedes Pharma said.” View full resource at health.yahoo.net
Most Recently Shared on July 2, 2011 at 6:40 am By:
Lazanda Approved for Cancer Pain http://bit.ly/ioaygh
Archimedes wins FDA approval for cancer pain spray - FierceBiotech
fiercebiotech.com — “The FDA has approved Archimedes' application for Lazanda, a fentanyl spray for cancer patients with breakthrough pain. The system is already approved in five other countries under the name PecFent. Read more...” View full resource at fiercebiotech.com
Most Recently Shared on July 1, 2011 at 5:08 pm By:
Archimedes wins FDA approval for cancer pain spray. http://bit.ly/lB8mU7
Lazanda Approved for Breakthrough Cancer Pain - ONA
oncologynurseadvisor.com — “Archimedes Pharma U.S. Inc. announced that the FDA has approved Lazanda (fentanyl) nasal spray for the management of breakthrough pain in cancer patients ?18 years who are already receiving and are tolerant to opioid therapy for their underlying persistent cancer pain.” View full resource at oncologynurseadvisor.com
Most Recently Shared on July 1, 2011 at 1:57 pm By:
OncologyNurseAdvisor Oncology, Nursing, Medical Education, and Medical Publisher
Lazanda Approved for Breakthrough Cancer Pain http://goo.gl/fb/koVKh
FDA Approves Lazanda® - First Fentanyl Nasal Spray - For The Management Of Breakthrough Pain In Cancer Patients
medicalnewstoday.com — “Archimedes Pharma Ltd., and its subsidiary, Archimedes Pharma U.S. Inc., announced that the U.S. Food and Drug Administration (FDA) has approved Lazanda® (fentanyl) nasal spray for the managem” View full resource at medicalnewstoday.com
Most Recently Shared on July 1, 2011 at 8:05 am By:
FDA Approves Lazanda® - First Fentanyl Nasal Spray - For The Management Of Breakthrough Pain In Cancer Patients http://mnt.to/3XSk
FDA Approves First Fentanyl Nasal Spray for Cancer Pain - QualityPoint Technologies
qualitypointtech.net — “The FDA has approved the first fentanyl nasal spray to treat breakthrough pain in cancer patients who are opioid tolerant. Medscape Medical News” View full resource at qualitypointtech.net
Most Recently Shared on July 1, 2011 at 1:45 am By:
FDA Approves First Fentanyl Nasal Spray for Cancer Pain: The FDA has approved the first fentanyl nasal spray to tr... http://bit.ly/jQEYgl
FDA Approves Lazanda - First Fentanyl Nasal Spray - for the Management of Breakthrough Pain in Cancer Patients
drugs.com — “Lazanda (fentanyl) nasal spray is used to treat breakthrough pain in cancer patients. Includes Lazanda side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on July 1, 2011 at 1:08 am By:
Drugs and Devices OW OW Health
FDA Approves Lazanda - First Fentanyl Nasal Spray - for the Management of Breakthrough Pain in Cancer Pati... http://bit.ly/mxmtJE #drug
Advertisement
